Results

Total Results: 894 records

Showing results for "diabetic".
Users also searched for: diabetes

  1. effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
    May 01, 2021 - CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update Comparative Effectiveness Review Number 244 Safety of Vaccines Used for Routine Immunization in the United States: An Update Evidence Summary Main Points Background and Purpose Considere…
  2. effectivehealthcare.ahrq.gov/sites/default/files/community-based-participatory-research-slides.pptx
    January 01, 2013 - Slide 1 Community-Based Participatory Research: Lessons for Stakeholder Engagement in Patient-Centered Outcomes Research June 19th, 2013 Numeric
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
    January 01, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
    January 01, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low 19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate 22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR Toth, 2012 None Low NPP Diabetic
  5. effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/clinician-2016
  6. effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/clinician
  7. effectivehealthcare.ahrq.gov/products/treatment-outcomes-diabetes/rapid-research
  8. effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/espanol
  9. effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/espanol-2017
  10. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - could present an opportunity to simplify treatment for the large proportion of patients who are both diabetic … randomized controlled trial, SCALE™ (Satiety and Clinical Adiposity-Liraglutide Evidence in Non- diabetic … and Diabetic people).49 The trial includes more than 5,000 patients who are either overweight (BMIs
  11. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - phentermine- topiramate and could present an opportunity to simplify treatment for patients who are both diabetic … randomized controlled trial, SCALE™ (Satiety and Clinical Adiposity-Liraglutide Evidence in Non- diabetic … and Diabetic people).56 The trial includes more than 5,000 patients who are either overweight (BMIs
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
    January 25, 2011 - Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 Cardiovascular Issues Data Points #8 Between 2007 and 2009, 87 to 88 percent of Medicare beneficiaries with hypertension used at least one prescription for an antihypertensive drug. Beneficiaries with hyp…
  13. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-nutrition-grand-rounds.pptx
    September 08, 2025 - AHRQ Slide Template-Widescreen AHRQ Evidence-based Practice Center Program Grand Rounds Series Topic: Nutrition Welcome and thank you for joining! September 8, 2025 Moderators 2 Elizabeth Cope, Ph.D., M.P.H. Chief Programs and Science Officer – AcademyHealth Lucy Savitz, Ph.D., M.B.A. Professor – University…
  14. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - Layout 1 Background Atherosclerosis develops in a patchy, discontinuous fashion within coronary arteries. Therefore, it is possible to treat the discrete areas of obstruction that most impede coronary blood flow to the myocardium. The mechanical approaches to coronary revascularization fall broadly into two categor…
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
    January 01, 2007 - Survey of Medicare Part D Plans’ Medication Therapy Management Programs Effective Health Care Research Reports Number 1 Survey of Medicare Part D Plans’ Medication Therapy Management Programs Daniel R. Touchette, Pharm.D., M.A. Anne L. Burns, R.Ph. Marcie A. Bough, Pharm.D. Juan C. Blackburn, M.D., M.B.…
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-centered-medical-home_research-protocol.pdf
    February 23, 2012 - Intermediate patient outcomes (e.g., change in HbA1c for diabetic patients). b. … Intermediate patient outcomes (e.g., change in HbA1c for diabetic patients). ii.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
    December 01, 2010 - Major: mortality, cerebrovascular disease-related events, development of diabetes mellitus, diabetic …  Major: mortality, cerebrovascular disease- related events, development of diabetes mellitus, diabetic … adverse events: mortality, cerebrovascular disease-related events, development of diabetes mellitus, diabetic
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
    December 01, 2022 - Executive Summary_Comparative Effectiveness Review No. 254: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication Comparative Effectiveness Review Number 254 Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication Executive Summary Main Points • Use …
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic … placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic … 0/32 (0%) WAE: 2/34 (5.88%) vs. 0/32 (0%) NR Selvarajah, 2010 High RCT Neuropathic pain- diabetic … (0%) vs. 0/18 (0%) WAE: 1/20 (5%) vs. 1/20 (5%) NR Toth, 2012 Low RCT Neuropathic pain- diabetic … Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic … placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic … 0/32 (0%) WAE: 2/34 (5.88%) vs. 0/32 (0%) NR Selvarajah, 2010 High RCT Neuropathic pain- diabetic … (0%) vs. 0/18 (0%) WAE: 1/20 (5%) vs. 1/20 (5%) NR Toth, 2012 Low RCT Neuropathic pain- diabetic … Efficacy of inhaled cannabis on painful diabetic neuropathy.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: